Overview: Blood Lead Level TestIntroduction: The Blood Lead Level Test measures lead levels in blood to detect lead poisoning, which can cause developmental delays, fatigue, or neurological issues, especially in children, helping guide treatment. Affecting 1 in 1,000 children annually, lead poisoning poses diagnostic challenges due to subtle symptoms. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses ICP-MS for high accuracy, supporting toxicology screening. This test is vital for diagnosis, intervention, and improving outcomes in pediatrics.
Other Names: Lead Toxicity Test, Blood Lead Concentration Assay.
FDA Status: Laboratory-developed test (LDT), meeting toxicology standards for diagnostic reliability.
Historical Milestone: Lead testing began in the 1970s with research by Needleman, who linked it to developmental issues. ICP-MS advancements in the 1990s by companies like PerkinElmer improved detection, surpassing earlier atomic absorption methods.
Purpose: Measures lead concentration to diagnose lead poisoning, guides chelation therapy, and evaluates children with developmental delays, aiming to prevent neurological damage.
Test Parameters: Lead concentration
Pretest Condition: No special preparation required. Collect whole blood. Report history of lead exposure.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in Na Heparin tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document developmental delay or fatigue. Include current medications or exposure history (e.g., paint, soil).
Consent: Written consent required, detailing the test's purpose, poisoning risks (e.g., brain damage), and sample collection risks.
Procedural Considerations: Uses ICP-MS to measure lead, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample contamination or delay can affect results. Medications may not affect results but require correlation.
Clinical Significance: Elevated lead confirms poisoning, guiding chelation. Early treatment might prevent damage, while untreated cases lead to disability. Normal levels may require follow-up.
Specialist Consultation: Consult a pediatrician or toxicologist for interpretation.
Additional Supporting Tests: X-ray fluorescence, zinc protoporphyrin, or environmental assessment to confirm diagnosis.
Test Limitations: Non-specific for source; correlation with exposure needed. False negatives possible with low exposure.
References: CDC Guidelines, 2023; Pediatrics, Needleman HL, 2022.
